Related Experiment Videos
Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1
Tiina E Raevaara1, Mari K Korhonen, Hannes Lohi
1Department of Biological and Environmental Sciences, University of Helsinki, Finland.
Gastroenterology
|August 9, 2005
Summary
Germline MLH1 mutations in hereditary nonpolyposis colorectal cancer can impair DNA repair in various ways. Severe defects correlate with early onset and high microsatellite instability, while milder defects show varied clinical outcomes.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Germline mutations in mismatch repair genes, like MLH1, are linked to hereditary nonpolyposis colorectal cancer (HNPCC).
- Nontruncating MLH1 mutations often present with diverse clinical phenotypes, variable microsatellite instability, and residual protein, suggesting impaired but not absent function.
- Understanding the pathogenicity of these mutations is crucial for genetic counseling and risk assessment in HNPCC families.
Purpose of the Study:
- To investigate the functional impact of 31 nontruncating MLH1 mutations found in colorectal cancer families.
- To elucidate the pathogenic mechanisms underlying these MLH1 alterations.
- To correlate biochemical findings with clinical phenotypes and assess predictive value of sequence homology.
Main Methods:
- Site-directed mutagenesis was used to create MLH1 variants.
- Functional assays assessed protein expression, stability, localization, protein-protein interactions, and in vitro repair efficiency.
- Genetic and biochemical data were correlated with clinical information; comparative sequence analysis was performed.
Main Results:
- Twenty-two of 34 MLH1 variants were pathogenic in multiple assays; 2 were impaired in one assay, and 10 behaved like wild-type.
- Twenty mutations affected MLH1 protein quantity, while 15 (mostly N-terminal) showed defects in in vitro repair.
- Comparative sequence analysis accurately predicted functional outcomes for 82% of the variants.
Conclusions:
- Pathogenic nontruncating MLH1 alterations can disrupt multiple biochemical functions.
- Severe functional defects correlate with aggressive phenotypes like early onset and high microsatellite instability.
- Mild or absent functional defects are associated with variable clinical presentations in HNPCC.